These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 18184044)
1. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets. Ye Z; Huang H; Hao S; Xu S; Yu H; Van Den Hurk S; Xiang J J Interferon Cytokine Res; 2007 Dec; 27(12):1031-8. PubMed ID: 18184044 [TBL] [Abstract][Full Text] [Related]
2. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
3. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. McMenamin C; Holt PG J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390 [TBL] [Abstract][Full Text] [Related]
4. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity. Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685 [TBL] [Abstract][Full Text] [Related]
5. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity. Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190 [TBL] [Abstract][Full Text] [Related]
7. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. Koenen HJ; Fasse E; Joosten I J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842 [TBL] [Abstract][Full Text] [Related]
8. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene. Ankathatti Munegowda M; Xu S; Freywald A; Xiang J Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785 [TBL] [Abstract][Full Text] [Related]
9. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice. Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222 [TBL] [Abstract][Full Text] [Related]
10. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability. Periasamy P; O'Neill HC Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375 [TBL] [Abstract][Full Text] [Related]
11. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742 [TBL] [Abstract][Full Text] [Related]
12. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781 [TBL] [Abstract][Full Text] [Related]
13. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation. Kezuka T; Streilein JW Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601 [TBL] [Abstract][Full Text] [Related]
14. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889 [TBL] [Abstract][Full Text] [Related]
16. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte. Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998 [TBL] [Abstract][Full Text] [Related]
17. Enhanced suppression of polyclonal CD8 Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells. Carbonneil C; Saidi H; Donkova-Petrini V; Weiss L Int Immunol; 2004 Jul; 16(7):1037-52. PubMed ID: 15184347 [TBL] [Abstract][Full Text] [Related]
19. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495 [TBL] [Abstract][Full Text] [Related]
20. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12. Homma S; Komita H; Sagawa Y; Ohno T; Toda G Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]